IMARC Group has recently released a new research study titled “South Korea Enzymes Market Size, Share, Trends and Forecast by Type, Source, Reaction Type, Application, and Region, 2025-2033”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
South Korea Enzymes Market Overview
The South Korea enzymes market size reached USD 265.43 Million in 2024 and is projected to grow to USD 521.17 Million by 2033, at a CAGR of 6.98% during 2025-2033. Market growth is driven by rising demand for digestive health supplements amongst seniors and advancements in enzyme therapeutics. Innovations in biotech and consumer health trends are expanding applications across health, wellness, and pharmaceuticals.
Study Assumption Years
- Base Year: 2024
- Historical Years: 2019-2024
- Forecast Period: 2025-2033
South Korea Enzymes Market Key Takeaways
- Current Market Size: USD 265.43 Million (2024)
- CAGR: 6.98% (2025-2033)
- Forecast Period: 2025-2033
- The elderly population (65+ years) was 19.2% in 2024 and expected to exceed 20% by 2025, reaching 30% by 2036, fueling demand for enzyme-based digestive health products.
- Enzyme-enhanced health supplements for lactose digestion, protein breakdown, and gut wellness are increasingly popular in capsule, powder, and liquid forms.
- Advances in RNA interference (RNAi) technologies are empowering enzyme therapeutics, especially for metabolic and inflammatory diseases.
- Successful ventures like the $660 million OliX Pharmaceuticals and Eli Lilly licensing deal illustrate growing biotech investments.
- Consumer preferences align with traditional enzyme-rich foods like kimchi and doenjang, supporting market growth.
Sample Request Link: https://www.imarcgroup.com/south-korea-enzymes-market/requestsample
Market Growth Factors
South Korea's aging population is a primary growth driver in the enzymes market. With 19.2% of the population aged 65 or above in 2024—a number expected to surpass 20% by 2025 and reach 30% by 2036—there is robust demand for enzyme-based digestive health supplements. Elderly individuals typically produce fewer digestive enzymes, leading to reduced nutrient absorption and gastrointestinal issues. Consequently, local companies are expanding enzyme-enhanced supplement offerings, aiding lactose digestion and protein breakdown, which supports gastrointestinal wellness.
The rise of e-commerce and pharmacies has increased accessibility to these enzyme products, which are available in convenient capsule, powder, or liquid formats with clear labeling. Additionally, the cultural affinity for enzyme-rich fermented foods such as kimchi and doenjang integrates traditional dietary preferences with modern enzyme supplements, further driving adoption among the elderly population and caregivers seeking preventive non-prescription health options.
Another key market growth factor is the advancement in enzyme therapeutics fueled by RNA interference (RNAi) technologies. RNAi enables precise gene silencing targeting enzymes linked to metabolic and inflammatory diseases, offering improved therapeutic specificity. South Korean biotech firms benefit from genomic research capabilities, simplified regulations, and global pharmaceutical collaborations, accelerating clinical development. The 2025 global licensing deal between OliX Pharmaceuticals and Eli Lilly, valued at $660 million, exemplifies these innovations targeting liver and cardiometabolic conditions, signaling strong investment and future product pipelines in enzyme-targeting treatments.
Market Segmentation
- Type Insights:
- Protease: Enzymes that break down proteins into peptides or amino acids, widely used in health and industrial applications.
- Carbohydrase: Enzymes that catalyze the breakdown of carbohydrates, important in food processing and bioenergy.
- Lipase: Enzymes involved in fat digestion and metabolism, used in pharmaceuticals and food sectors.
- Polymerase and Nuclease: Enzymes important in genetic and biotech applications, involved in DNA/RNA synthesis and modification.
- Others: Additional enzyme types serving various industrial and biotechnological roles.
- Source Insights:
- Microorganisms: Enzymes produced by bacteria, fungi, and other microbes, contributing to industrial enzyme supply.
- Plants: Plant-derived enzymes used in food, pharmaceutical, and industrial processes.
- Animals: Animal-sourced enzymes applied in healthcare and biotechnology.
- Reaction Type Insights:
- Hydrolase: Enzymes catalyzing hydrolysis reactions, central to digestion and biochemical processes.
- Oxidoreductase: Enzymes facilitating oxidation-reduction reactions important in metabolism.
- Transferase: Enzymes transferring functional groups, critical in cellular functions and biotechnology.
- Lyase: Enzymes breaking chemical bonds without hydrolysis or oxidation, used in bioprocessing.
- Others: Additional enzyme reaction types relevant to specialized applications.
- Application Insights:
- Food and Beverages: Enzymes used for food processing, preservation, and flavor enhancement.
- Household Care: Enzymes incorporated into cleaning products and detergents.
- Bioenergy: Enzyme use in biofuel production and sustainability applications.
- Pharmaceutical and Biotechnology: Enzymes applied in drug development, diagnostics, and therapeutic treatments.
- Feed: Enzymes improving animal nutrition and feed efficiency.
- Others: Various other applications including industrial and environmental.
Ask For an Analyst- https://www.imarcgroup.com/request?type=report&id=39897&flag=C
Regional Insights
The report covers major regions including Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), and others. The dominant region is not explicitly provided in the source. Specific statistics for regional market shares or CAGR are not provided.
South Korea's enzymes market benefits from widespread regional adoption, with focus areas spread across key population and industrial centers.
Recent Developments & News
In May 2025, Jack Daniel’s launched its premium aged whiskeys, including the 10-Year-Old and Bonded Rye, in South Korea. The company's Master Distiller Chris Fletcher highlighted the traditional use of enzymes since 1938 in the brand’s charcoal mellowing process, enhancing whiskey smoothness and flavor.
In December 2024, researchers at the Korea Bioinformation Center successfully mass-cultivated enzymes from honeybee moths capable of breaking down regular plastic using yeast and insect cells. This eco-friendly enzyme method offers new ways to address plastic waste beyond biodegradable plastics. The enzyme's decomposition mechanism was enhanced using AI and genetic modification, with findings published in the Journal of Hazardous Materials.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
